Perspective Therapeutics (CATX) FCF Margin Growth (5y) (2015 - 2023)
Powered by 
Analysis
Perspective Therapeutics (CATX) FCF Margin Growth (5y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Perspective Therapeutics | 358.23 Mn | 358.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 24,992.00 |
| Sep 30, 2023 | -36,259.00 |
| Jun 30, 2023 | -31,623.00 |
| Mar 31, 2023 | -40,724.00 |
| Sep 30, 2022 | 5,330.00 |
| Jun 30, 2022 | 2,512.00 |
| Mar 31, 2022 | 7,022.00 |
| Dec 31, 2021 | 26,879.00 |
| Sep 30, 2021 | 5,538.00 |
| Jun 30, 2021 | 8,191.00 |
| Mar 31, 2021 | 5,442.00 |
| Dec 31, 2020 | 3,606.00 |
| Sep 30, 2020 | 6,935.00 |
| Jun 30, 2020 | 1,275.00 |
| Mar 31, 2020 | 6,906.00 |
| Jun 30, 2019 | 4,852.00 |
| Mar 31, 2019 | -3,184.00 |
| Dec 31, 2018 | 1,474.00 |
| Sep 30, 2018 | -2,534.00 |
| Jun 30, 2018 | -3,364.00 |